Donepezil may delay nursing home admission in moderate to severe Alzheimer’s disease Discontinuing donepezil in Alzheimer’s patients as their disease worsens could double the risk of admission into a nursing home within a year, suggests a study published in The Lancet Neurology.…
Antipsychotic drug aripiprazole could aid antidepressant therapies in older adults Elderly patients with depression who are not helped by a first-line antidepressant could benefit from the addition of an antipsychotic drug, finds a study published in The Lancet.…
How working in non-pharmacy placements can benefit students’ professional development Role-emerging placements enable pharmacy students in all years to work with members of the public and learn about their needs.…
Pharmacists must prepare for changing NHS, RPS conference hears The pharmacy profession will need to adapt its clinical practice within a changing NHS as the health service adjusts to meet demand, attendees at the Royal Pharmaceutical Society’s annual conference heard.…
Stopping antihypertensives does not slow cognitive decline in older patients In patients over 75 years, low blood pressure can worsen cognitive decline, but researchers found that stopping antihypertensives did not help.…
Widespread prescribing of antipsychotics for intellectually disabled people revealed As many as 71% of adults with a learning disability were prescribed an antipsychotic when they had no record of any mental illness, a study reported in The BMJ has found.…
Specialist roles in hospital pharmacy Pharmacy professionals have the opportunity to specialise in a variety of clinical areas. Eamonn McArdle explores the possibilities.…
Omega-3 supplements fail to slow cognitive decline Using supplements of omega-3 fatty acids or other nutrients found in green leafy vegetables does not slow down cognitive decline in older people, according to new research.…
MHRA review concludes alteplase is safe for treating acute ischaemic stroke The Medicines and Healthcare products Regulatory Agency has backed the continued use of the thrombolytic drug alteplase for up to 4.5 hours after the onset of symptoms of acute ischaemic stroke.…
Clinical Pharmacist’s monthly news round-up: the top 10 in the past month What has been happening in the world of pharmacy? Here’s our pick of must-read news from the past month.…
